Search results for "Pulmonary and Respiratory Medicine"

showing 10 items of 1498 documents

Should we use gait speed in COPD, FEV 1 in frailty and dyspnoea in both?

2016

Frailty is a progressive physiological decline in multiple organ systems marked by loss of function, loss of physiological reserve and increased vulnerability to disease [1]. Biological (inflammation and loss of hormones), clinical ( e.g. sarcopenia and osteoporosis) and social factors are involved in frailty onset, evolution and prognosis [2, 3]. Links between frailty, dyspnoea and chronic respiratory diseases represent a novel and practical approach

Pulmonary and Respiratory Medicinemedicine.medical_specialty[SDV]Life Sciences [q-bio]OsteoporosisDiseaseIdoso FragilizadoDispneia03 medical and health sciencesPulmonary Disease Chronic Obstructive0302 clinical medicineInternal medicineForced Expiratory VolumemedicineHumans030212 general & internal medicineLoss functionOrgan systemComputingMilieux_MISCELLANEOUSAgedAged 80 and overCOPDFrailtybusiness.industrymedicine.disease3. Good healthGait speedWalking SpeedPreferred walking speedDyspnea030228 respiratory systemSarcopeniaPhysical therapyCardiologyDoença Pulmonar Obstrutiva CrónicaVolume Expiratório ForçadoAged; Aged 80 and over; Dyspnea; Forced Expiratory Volume; Frailty; Humans; Pulmonary Disease Chronic Obstructive; Walking Speed; Pulmonary and Respiratory MedicinebusinessHuman
researchProduct

Intravenous Immunoglobulin as a Third-Line Therapy in Chronic Spontaneous Urticaria

2010

Pulmonary and Respiratory Medicinemedicine.medical_specialtybiologybusiness.industryInternal medicineImmunologybiology.proteinThird-line therapyImmunology and AllergyMedicineAntibodybusinessGastroenterologyAnnals of Allergy, Asthma & Immunology
researchProduct

One-year follow up of asthmatic patients newly initiated on treatment with medium- or high-dose inhaled corticosteroid-long-acting β2-agonist in UK p…

2020

Abstract Introduction Global Initiative for Asthma (GINA) recommends medium- or high-dose inhaled corticosteroid-long-acting β2-agonist (ICS-LABA) as preferred treatments for patients with moderate-to-severe asthma. Limited data is available on how step 4/5 patients respond to ICS-LABA and how they step up/down in clinical practice. Methods This retrospective cohort study assessed the characteristics, control status, treatment pathways, and healthcare resource utilization in patients with asthma during one year after initiating medium- or high-dose ICS-LABA. Data from the United Kingdom Clinical Practice Research Datalink were analysed between January 01, 2006 and February 28, 2016. Results…

Pulmonary and Respiratory Medicinemedicine.medical_specialtybiologymedicine.drug_classLeukotriene receptorbusiness.industryAntagonistMuscarinic antagonistRetrospective cohort studyLamamedicine.diseasebiology.organism_classification03 medical and health sciences0302 clinical medicine030228 respiratory systemInternal medicineCohortmedicineCorticosteroid030212 general & internal medicinebusinessAsthmamedicine.drugRespiratory Medicine
researchProduct

Inherited Thrombophilic Risk Factors and Venous Thromboembolism

2000

Study objectives To investigate whether the FIIA20210 mutation is associated with isolated pulmonaryembolism (PE). Design Case-control study. Setting Five thrombosis centers in southern Italy. Patients Six hundred forty-seven consecutive referredpatients with objectively documented venous thrombosis and 1,329control subjects. Measurements and results Medicalhistories were collected. The G-to-A transition at nucleotide 1691within the factor V gene (FV Leiden) and the G-to-A transition atnucleotide position 20210 within the prothrombin gene locus (FIIA20210), levels of anticoagulant factors, and levelsof antiphospholipid antibodies were determined by standard techniques.Patients with deep ven…

Pulmonary and Respiratory Medicinemedicine.medical_specialtybiologymedicine.drug_classbusiness.industryDeep veinAnticoagulantFactor VCritical Care and Intensive Care Medicinemedicine.diseaseGastroenterologyThrombosisSurgeryPulmonary embolismVenous thrombosismedicine.anatomical_structureInternal medicinemedicineFactor V Leidenbiology.proteinRisk factorCardiology and Cardiovascular MedicinebusinessChest
researchProduct

Management of acute pulmonary embolism: towards a (truly) global reach

2021

The study by Z. Zhai and colleagues provides an overview of the developments observed as risk-adapted management strategies for acute pulmonary embolism have been progressively introduced and optimised in the Chinese healthcare systemhttps://bit.ly/3swGht2

Pulmonary and Respiratory Medicinemedicine.medical_specialtybusiness.industry10031 Clinic for AngiologyMEDLINE610 Medicine & healthmedicine.diseasePulmonary embolism2740 Pulmonary and Respiratory MedicineHealth careAcute DiseaseMedicineHumansbusinessIntensive care medicinePulmonary Embolism
researchProduct

Metabolic aspects of obstructive sleep apnoea syndrome.

2009

Insulin resistance is often associated with obstructive sleep apnoea syndrome (OSAS) and could contribute to cardiovascular risk in OSAS. Sleep loss and intermittent hypoxia could contribute to the pathogenesis of the metabolic alterations associated with obesity, a common feature of OSAS. The biology of the adipocyte is being increasingly studied, and it has been found that hypoxia negatively affects adipocyte function. In November 2007, the European Respiratory Society and two EU COST Actions (Cardiovascular risk in OSAS (B26) and Adipose tissue and the metabolic syndrome (BM0602)), held a Research Seminar in Du¨sseldorf, Germany, to discuss the following: 1) the effects of hypoxia on glu…

Pulmonary and Respiratory Medicinemedicine.medical_specialtybusiness.industryAdipose tissueIntermittent hypoxiaInflammationHypoxia (medical)Settore MED/10 - Malattie Dell'Apparato Respiratoriomedicine.diseaseObesitynervous system diseasesrespiratory tract diseaseschemistry.chemical_compoundEndocrinologyInsulin resistancestomatognathic systemchemistryAdipokines adipose tissue inflammation insulin resistance hypoxia treatmentAdipocyteInternal medicinemedicinemedicine.symptomMetabolic syndromebusiness
researchProduct

Clinical evidence from randomized trials, network meta-analyses, and conflicts of interests

2013

Pulmonary and Respiratory Medicinemedicine.medical_specialtybusiness.industryAlternative medicinelaw.inventionsurgical procedures operativeRandomized controlled trialNetwork Meta-AnalysesClinical evidencelawAntifibrinolytic agentcardiovascular systemmedicineSurgeryAprotinincardiovascular diseasesCardiology and Cardiovascular MedicineIntensive care medicinebusinessmedicine.drugThe Journal of Thoracic and Cardiovascular Surgery
researchProduct

Autogenous Reconstruction of Infected Arterial Prosthetic Grafts Utilizing the Superficial Femoral Vein1

2001

BACKGROUND Prosthetic infection after reconstructive vascular surgery is a most serious complication, associated with high mortality and amputation rates. Following excision of the infected graft, several methods of reconstruction are available. We present here our experience with autogenous reconstruction of infected prosthetic arterial grafts using the superficial femoral vein (SFV). METHODS From November 1995 to December 1999, we used the SFV in seven patients (mean age 70 years) for reconstruction of an infected aortobifemoral (n = 2), aortoiliac (n = 1), femorofemoral bypass (n = 1), femorotibial (n = 2) and carotid crossover bypass (n = 1). Treatment encompassed complete prosthetic ex…

Pulmonary and Respiratory Medicinemedicine.medical_specialtybusiness.industryBasilic Veinmedicine.medical_treatmentFemoral veinPerioperativeVascular surgeryAsymptomaticSurgeryAmputationPopliteal veinMedicineSurgerymedicine.symptomCardiology and Cardiovascular MedicinebusinessComplicationThe Thoracic and Cardiovascular Surgeon
researchProduct

Chronic thromboembolic disease following pulmonary embolism: more work ahead

2020

Pulmonary and Respiratory Medicinemedicine.medical_specialtybusiness.industryCardiologyMEDLINEmedicine.diseasePulmonary embolismWork (electrical)ThromboembolismAcute DiseasemedicineHumansThromboembolic diseasePulmonary EmbolismIntensive care medicinebusinessEuropean Respiratory Journal
researchProduct

Klappenerhaltende Resektion eines Fibroelastoms

2002

Papillare Fibroelastome sind seltene und gutartige Tumore des Herzens mit bevorzugter Lokalisation im Bereich der Klappen, die mit schwersten Komplikationen oder fatalen und malignem Verlaufen einhergehen konnen. In diesem Fallbericht wird uber eine modifizierte, klappenerhaltende Operationstechnik eines symptomatischen Fibroelastoms an der Aortenklappen berichtet.

Pulmonary and Respiratory Medicinemedicine.medical_specialtybusiness.industryCardiothoracic surgeryMedicineSurgeryCardiology and Cardiovascular MedicinebusinessNuclear medicineZeitschrift f�r Herz-, Thorax- und Gef��chirurgie
researchProduct